Stage Iii Breast Cancer Ajcc V6: Disease Bioinformatics
Breast cancer begins in the breast typically as a ductal carcinoma and can affect men or women. It is the second most commonly diagnosed cancer of women in the United States. Risk for developing breast cancer increases with age, family history, gene mutations on BRCA1 and BRCA2, obesity, radiation exposure, early onset of puberty, never having kids, postmenopausal hormone therapy, and excessive alcohol intake. Treatment for breast cancer includes: surgery, radiation therapy, chemotherapy, hormone therapy, alternative medicine, and medications. Stage III breast cancer can be divided into subgroups IIIA, IIB, and IIC. In this stage, the cancerous cells have not spread to distant sites throughout the body, but the cells may be found in several axillary lymph nodes. A large tumor may develop at this stage that can grow into the chest wall or skin of the breast. Stage IIIC may be operable or inoperable, depending on how the growth has developed overtime.
Stage Iii Breast Cancer Ajcc V6 Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage Iii Breast Cancer Ajcc V6 below!
For more information on how to use Laverne, please read the How to Guide.
We have 2579 products for the study of Stage Iii Breast Cancer Ajcc V6 that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits.